RUNX3 methylation and expression associated with advanced precancerous gastric lesions in a Chinese population

Carcinogenesis

Volumn 32, Issue 3, 2011, Pages 406-410

  Li, Wen Qing ^a   Pan, Kai Feng ^a   Zhang, Yang ^a   Dong, Cai Xuan ^a   Zhang, Lian ^a   Ma, Jun Ling ^a   Zhou, Tong ^a   Li, Ji You ^a   You, Wei Cheng ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR RUNX3;

ADULT; ADVANCED CANCER; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRITIS; GASTROINTESTINAL DYSPLASIA; HELICOBACTER INFECTION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; STOMACH LESION;

EID: 79952306113     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq259     Document Type: Article

References (41)

1. Boyle,P. et al. (2008) World Cancer Report 2008., Vol. 503, International Agency for Research on Cancer, Lyon, France.
2. You,W.C. et al. (1999) Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer. Int. J. Cancer, 83, 615-619.
3. You,W.C. et al. (1993) Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res., 53, 1317-1321.
4. Correa,P. (1992) Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res., 52, 6735-6740.
5. Subramaniam,M.M. et al. (2009) Molecular pathology of RUNX3 in human carcinogenesis. Biochim. Biophys. Acta, 1796, 315-331.
6. Li,Q.L. et al. (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell, 109, 113-124.
7. Fukamachi,H. et al. (2004) Growth regulation of gastric epithelial cells by Runx3. Oncogene, 23, 4330-4335.
8. Bae,S.C. et al. (2004) Tumor suppressor activity of RUNX3. Oncogene, 23, 4336-4340.
9. Zaidi,S.K. et al. (2002) Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites. Proc. Natl Acad. Sci. USA, 99, 8048-8053.
10. Derynck,R. et al. (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet., 29, 117-129.
11. Blyth,K. et al. (2005) The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer, 5, 376-387.
12. Fukamachi,H. et al. (2004) Runx3-/-gastric epithelial cells differentiate into intestinal type cells. Biochem. Biophys. Res. Commun., 321, 58-64.
13. Fukamachi,H. (2006) Runx3 controls growth and differentiation of gastric epithelial cells in mammals. Dev. Growth Differ., 48, 1-13.
14. Wei,D. et al. (2005) Loss of RUNX3 expression significantly affects the clinical outcome of gastric cancer patients and its restoration causes drastic suppression of tumor growth and metastasis. Cancer Res., 65, 4809-4816.
15. Hsu,P.I. et al. (2009) Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer. Ann. Surg. Oncol., 16, 1686-1694.
16. Bangsow,C. et al. (2001) The RUNX3 gene-sequence, structure and regulated expression. Gene, 279, 221-232.
17. So,K. et al. (2006) Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray. Pathol. Int., 56, 571-575.
18. Oshimo,Y. et al. (2004) Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Pathobiology, 71, 137-143.
19. Kim,T.Y. et al. (2004) Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab. Invest., 84, 479-484.
20. Osaki,M. et al. (2004) Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma. Eur. J. Clin. Invest., 34, 605-612.
21. Dong,C.X. et al. (2009) Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a populationbased study. Int. J. Cancer, 124, 434-439.
22. Nie,X.R. et al. (2009) Association between promoter methylation of cyclooxygenase-2 and expression, and precancerous gastric lesions in a high-risk population. Zhonghua Yu Fang Yi Xue Za Zhi, 43, 571-575.
23. Dixon,M.F. et al. (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am. J. Surg. Pathol., 20, 1161-1181.
24. Rugge,M. et al. (2000) Gastric dysplasia: the Padova international classification. Am. J. Surg. Pathol., 24, 167-176.
25. Zhang,L. et al. (2006) Eradication of H. pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy. World J. Gastroenterol., 12, 3915-3918.
26. Sun,Y. et al. (2004) Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study. Clin. Cancer Res., 10, 5087-5093.
27. Herman,J.G. et al. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA, 93, 9821-9826.
28. Waki,T. et al. (2003) Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci., 94, 360-364.
29. You,W.C. et al. (2000) Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J. Natl Cancer Inst., 92, 1607-1612.
30. You,W.C. et al. (2006) Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J. Natl Cancer Inst., 98, 974-983.
31. You,W.C. et al. (1988) Diet and high risk of stomach cancer in Shandong, China. Cancer Res., 48, 3518-3523.
32. Bae,S.C. et al. (2006) Phosphorylation, acetylation and ubiquitination: the molecular basis of RUNX regulation. Gene, 366, 58-66.
33. van Wijnen,A.J. et al. (2004) Nomenclature for Runt-related (RUNX) proteins. Oncogene, 23, 4209-4210.
34. Cohen, M.M.Jr. (2009) Perspectives on RUNX genes: an update. Am. J. Med. Genet., 149A, 2629-2646.
35. Guo,W.H. et al. (2002) Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Oncogene, 21, 8351-8355.
36. Hmadcha,A. et al. (1999) Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J. Exp. Med., 190, 1595-1604.
37. Chan,A.O. et al. (2003) Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut, 52, 502-506.
38. Kitajima,Y. et al. (2008) Helicobacter pylori infection is an independent risk factor for Runx3 methylation in gastric cancer. Oncol. Rep., 19, 197-202.
39. Katayama,Y. et al. (2009) Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages. Biochem. Biophys. Res. Commun., 388, 496-500.
40. Ito,K. et al. (2005) RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res., 65, 7743-7750.
41. Kim,W.J. et al. (2005) RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res., 65, 9347-9354.